The basic skeleton of triazole compounds is composed of a five-membered heterocyclic ring, which is composed of three nitrogen and two carbon atoms. Triazoles and their derivatives have important biological properties, including antibacterial, antiviral, anticancer, and other activities. Based on this, CD BioGlyco provides high-quality triazole skeleton-based vaccine development services.
We identify specific antigens against specific pathogens or diseases and perform antigen design according to their antigenic characteristics. For example, pathogen surface proteins, peptides, or sugar groups are used as potential antigens.
We provide antigen preparation services that induce strong immune responses in different ways, such as isolating and purifying the antigen or synthesizing peptides representing specific epitopes of the antigen.
We use chemical methods of solid-phase synthesis or liquid-phase synthesis to synthesize antigen vectors and select appropriate positions to introduce functional groups with click reactivity, such as alkynyl or azide groups. Commonly used sites for click reactions are alkynyl or azide groups on sugar molecules.
Triazole backbones are often used as linkers or scaffolds to connect different antigen components or delivery systems in vaccine development. We perform a click reaction between a ligand with an azide group and an antigen vector with an alkynyl group. This step promotes the cycloaddition reaction between the azide group and the alkynyl group to form a stable triazole skeleton.
We perform structural verification of the synthesized triazole backbone vaccine, for example, through nuclear magnetic resonance (NMR), mass spectrometry, and high-performance liquid chromatography (HPLC). At the same time, in vitro cell experiments and animal model experiments are used to evaluate the functions of the synthesized triazole skeleton vaccine, including its immunogenicity, stability, and safety. Moreover, we also provide further optimization and modification of the vaccine according to the evaluation results.
We provide large-scale production for selected triazole backbone vaccine candidate molecules to meet the needs of commercial production.
Fig.1 Triazole skeleton-based vaccine development service. (CD BioGlyco)
Technology: An azide-alkyne click chemistry approach
Journal: Bioorganic Chemistry
IF: 5.307
Published: 2021
Results: The authors used an azide-alkyne click chemistry approach to prepare a focused library of multiple novel Pam3CAG conjugates and tested their immunogenicity as adjuvants for exogenous subunit antigen (HBsAg) vaccines. The results showed that the ribose-derived conjugate (6e) had significant HBsAg-specific antibody (IgG) titers and had stronger cell-mediated immunity.
Fig.2 Click chemistry-based vaccine adjuvant development strategy. (Mhamane, et al., 2021)
CD BioGlyco has a multi-disciplinary professional technical team. We use click chemistry technology to provide personalized triazole skeleton-based vaccine design and development services according to the characteristics of specific pathogens or diseases. Please feel free to
if you are interested in our service.References